These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 12036002)

  • 21. The cost of treating addiction from the client's perspective: results from a multi-modality application of the Client DATCAP.
    McCollister KE; French MT; Pyne JM; Booth B; Rapp R; Carr C
    Drug Alcohol Depend; 2009 Oct; 104(3):241-8. PubMed ID: 19574000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The economic costs of quarterly monitoring and recovery management checkups for adults with chronic substance use disorders.
    Dennis ML; French MT; McCollister KE; Scott CK
    J Subst Abuse Treat; 2011 Sep; 41(2):201-7. PubMed ID: 21466944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment program operations and costs.
    Broome KM; Knight DK; Joe GW; Flynn PM
    J Subst Abuse Treat; 2012 Mar; 42(2):125-33. PubMed ID: 22154033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A research agenda for economic evaluation of substance abuse services.
    French MT; Drummond M
    J Subst Abuse Treat; 2005 Sep; 29(2):125-37. PubMed ID: 16135341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Longitudinal association of preference-weighted health-related quality of life measures and substance use disorder outcomes.
    Pyne JM; Tripathi S; French M; McCollister K; Rapp RC; Booth BM
    Addiction; 2011 Mar; 106(3):507-15. PubMed ID: 21205046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outpatient marijuana treatment for adolescents. Economic evaluation of a multisite field experiment.
    French MT; Roebuck MC; Dennis ML; Godley SH; Liddle HA; Tims FM
    Eval Rev; 2003 Aug; 27(4):421-59. PubMed ID: 12959043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Assessment of cost-benefit analysis in integration projects on drug addiction].
    Ates T; Langer B; Erbas B; Tretter F; Wehner B
    Gesundheitswesen; 2005 Feb; 67(2):159-62. PubMed ID: 15747208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of substance abuse treatment modality on birth weight and health care expenditures.
    Daley M; Argeriou M; McCarty D; Callahan JJ; Shepard DS; Williams CN
    J Psychoactive Drugs; 2001; 33(1):57-66. PubMed ID: 11333002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Costs and effectiveness of substance abuse treatments for homeless persons.
    Schumacher JE; Mennemeyer ST; Milby JB; Wallace D; Nolan K
    J Ment Health Policy Econ; 2002 Mar; 5(1):33-42. PubMed ID: 12529568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The outcome and cost of alcohol and drug treatment in an HMO: day hospital versus traditional outpatient regimens.
    Weisner C; Mertens J; Parthasarathy S; Moore C; Hunkeler EM; Hu T; Selby JV
    Health Serv Res; 2000 Oct; 35(4):791-812. PubMed ID: 11055449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does treatment 'pay for itself'? Looking at the economic argument for addiction treatment.
    Ettner SL
    Behav Healthc; 2006 May; 26(5):32-4. PubMed ID: 16736917
    [No Abstract]   [Full Text] [Related]  

  • 32. What Oregon's parity law can tell us about the federal Mental Health Parity and Addiction Equity Act and spending on substance abuse treatment services.
    McConnell KJ; Ridgely MS; McCarty D
    Drug Alcohol Depend; 2012 Aug; 124(3):340-6. PubMed ID: 22382046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Economic analysis of costs and consequences of the treatment of drug misuse: 2-year outcome data from the National Treatment Outcome Research Study (NTORS).
    Godfrey C; Stewart D; Gossop M
    Addiction; 2004 Jun; 99(6):697-707. PubMed ID: 15139868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outpatient treatment of cocaine addiction: suggestions to increase its effectiveness.
    Washton AM; Stone-Washton N
    Int J Addict; 1990-1991; 25(12A):1421-9. PubMed ID: 1966835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Costing substance misuse services.
    Coyle D; Godfrey C; Hardman G; Raistrick D
    Addiction; 1997 Aug; 92(8):1007-15. PubMed ID: 9376770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relative contribution of outcome domains in the total economic benefit of addiction interventions: a review of first findings.
    McCollister KE; French MT
    Addiction; 2003 Dec; 98(12):1647-59. PubMed ID: 14651494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Obtaining preference scores for an abbreviated self-completion version of the Teen-Addiction Severity Index (ASC T-ASI) to value therapy outcomes of systemic family interventions: a discrete choice experiment.
    Schawo S; Hoefman R; Reckers-Droog V; Lawerman-van de Wetering L; Kaminer Y; Brouwer W; Hakkaart-van Roijen L
    Eur J Health Econ; 2024 Jul; 25(5):903-913. PubMed ID: 37755542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The political and scientific challenges in evaluating compulsory drug treatment centers in Southeast Asia.
    Vuong T; Nguyen N; Le G; Shanahan M; Ali R; Ritter A
    Harm Reduct J; 2017 Jan; 14(1):2. PubMed ID: 28077147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Economic evaluation of drug abuse treatment programs: methodology and findings.
    French MT
    Am J Drug Alcohol Abuse; 1995 Feb; 21(1):111-35. PubMed ID: 7762538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Economic evaluation of a prerelease substance abuse treatment program for repeat criminal offenders.
    French MT; Fang H; Fretz R
    J Subst Abuse Treat; 2010 Jan; 38(1):31-41. PubMed ID: 19631489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.